PMVP compared with PLRX: revenue, margins and what each company keeps, and the suppliers and customers both name

PMVPPMV Pharmaceuticals, Inc.

Mkt capRevenueRevenue

PLRXPliant Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

PMVPPMV Pharmaceuticals, Inc.

PLRXPliant Therapeutics, Inc.

Price

Mkt cap

Revenue

Earnings history

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

last 4 reports each · paired by recencyMethod ›

PMVP1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▲+3.70%—

PLRX1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±55.4%▲+3.88%×0.07

= impliedPMVP realized, solidPLRX realized, hatchedOne scale, both sides: full bar = 56%× = |realized| ÷ impliedSource: market data

PMVPPMV Pharmaceuticals, Inc.

1.37▲+4.72%· post 1.37

Mkt cap$73.2MRevenue—

PLRXPliant Therapeutics, Inc.

0.85▼−1.46%· post 0.85

ClosedNov 2 '26

Mkt cap$53.2MRevenue$248,000Q2 FY23

Compare

ClosedNov 2 '26

PMVPPMV Pharmaceuticals, Inc.

PLRXPliant Therapeutics, Inc.

1.37▲+4.72%post 1.37

Price

0.85▼−1.46%post 0.85

$73.2M

Mkt cap

$53.2M

—

Revenue

$248,000Q2 FY23

PMVP1.37▲+4.72%vsPLRX0.85▼−1.46%ClosedNov 2 '26